Group 1 - The core point of the news is that Hualu Bio experienced a stock price increase of 5.07%, reaching 21.54 CNY per share, with a trading volume of 1.03 billion CNY and a turnover rate of 5.16%, resulting in a total market capitalization of 2.641 billion CNY [1] - Hualu Bio, established on June 8, 2010, and listed on April 12, 2021, is primarily engaged in the research, industrial cultivation, and sales of edible mushrooms, with revenue composition being 70.73% from enoki mushrooms and 29.27% from king oyster mushrooms [1] Group 2 - Among the top circulating shareholders of Hualu Bio, the Noan Multi-Strategy Mixed A Fund (320016) entered the top ten in the third quarter, holding 1.0993 million shares, which accounts for 1.17% of the circulating shares, with an estimated floating profit of approximately 1.1433 million CNY [2] - The Noan Multi-Strategy Mixed A Fund was established on August 9, 2011, with a latest scale of 1.855 billion CNY, achieving a year-to-date return of 5.18% and ranking 3365 out of 8836 in its category, while its one-year return is 89.88%, ranking 340 out of 8091 [2] Group 3 - The fund manager of Noan Multi-Strategy Mixed A Fund is Kong Xianzheng, who has been in the position for 5 years and 49 days, managing a total fund asset scale of 5.608 billion CNY, with the best fund return during his tenure being 93.39% and the worst being -16.74% [3]
华绿生物股价涨5.07%，诺安基金旗下1只基金位居十大流通股东，持有109.93万股浮盈赚取114.33万元